Ignite Creation Date:
2025-12-24 @ 6:58 PM
Ignite Modification Date:
2026-01-02 @ 8:39 AM
Study NCT ID:
NCT07281157
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-15
First Post:
2025-12-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Irinotecan Liposome Plus Capecitabine and Enronsubemab Combined With Short-course Radiotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cancer
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-01-25
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-12-01
First Submit QC Date:
None
Study First Post Date:
2025-12-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-12
Last Update Post Date:
2025-12-15
Last Update Post Date Type:
ESTIMATED